Soley Pharmaceutical Private Limited - Due diligence report

A 360° intelligence report on Soley Pharmaceutical Private Limited: trust score, financial health, credit view, compliance, directors, growt…

2018-09-19 Kalyan, Maharashtra Active Unlisted
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Soley Pharmaceutical Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
75/100
Trust Score
Low Risk

Soley Pharmaceutical Private Limited is assessed as Low Risk with a Trust Score of 75/100. Soley Pharmaceutical Private Limited is an active private limited indian non-government company incorporated in 2018, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 22 Nov 2026 from the latest processed filings. Soley Pharmaceutical Private Limited snapshot & full profile →

Overall Assessment CautionWeakNeutralGoodStrong Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
75/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
45/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
35/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 0 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 35/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Elevated gearing (D/E 38%).

Charges position: 0 open ( 48.0 cr ) · 0 satisfied ( 12.5 cr ).

Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
REHAN EJAZ KHAN 01234567 Director 01/04/2018 6 yrs Approved
SOHAIL MASOOM KHAN 01234567 Director 01/04/2018 6 yrs Approved
FAIZAN KHAN RAZZAQUE 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 60 · Distress 75
Growth signals & trust indicators
Steady revenue growth: +1.42 over 1 year(s).
Operating for 8 years.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence80/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment51/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view58/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 11 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
13 Jan 2022
Director ceased
MANOJ UTTAM SALVE
Director ceased
RENU RAMPRATAP PANDEY
Director ceased
ABDUL SALAM SHAIKH
Director ceased
SHABNAM ABDULSALAM SHAIKH
29 Nov 2021
Director appointed
REHAN EJAZ KHAN (Director)
Director appointed
SOHAIL MASOOM KHAN (Director)
Director appointed
FAIZAN KHAN RAZZAQUE (Director)
03 Jul 2019
Director ceased
Dinesh Siddhinath Shukla
19 Sep 2018
Incorporated
Registered with Roc Mumbai Ii
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 1 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Concept Biomedicals Private Limited U24232DL2011PTC213744 Delhi, Delhi, India
Biohealthcart Nutrio Private Limited U93000DL2019PTC350110 New Delhi, Delhi, India
Jef Medisys Private Limited U74999MH2018PTC303509 Thane, Maharashtra, India
Circulate Pharmaceuticals Private Limited U74999WB2016PTC218565 Kolkata, West Bengal, India
B.P.S. Pharmaceutical Private Limited U24100UP2014PTC062465 Ballia, Uttar Pradesh, India
Sterllink Display Private Limited U74300TN2005PTC055636 Chennai, Tamil Nadu, India
Ariaus Biosciences Private Limited U36912UP2016PTC075600 Kanpur, Uttar Pradesh, India
Neetaraa Global Exim Private Limited U24304UP2018PTC106873 Kanpur, Uttar Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Soley Pharmaceutical Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Soley Pharmaceutical Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 35/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 60/100, margin trends, ownership structure and peer set for Soley Pharmaceutical Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 75/100, distress signals and MSME payment-delay disclosures - know whether Soley Pharmaceutical Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Soley Pharmaceutical Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Soley Pharmaceutical Private Limited an active company?

Soley Pharmaceutical Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Soley Pharmaceutical Private Limited financially healthy?

Soley Pharmaceutical Private Limited has a Financial Health Score of 45/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Soley Pharmaceutical Private Limited?

Its overall Trust Score is 75/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Soley Pharmaceutical Private Limited?

See the directors and ownership sections above for board and shareholding detail. 3 active director(s) are on record.

Does Soley Pharmaceutical Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Soley Pharmaceutical Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Soley Pharmaceutical Private Limited?

Its Credit Risk Score is 35/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.